We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




DNA Breakages Speed Telomere Shortening

By Biotechdaily staff writers
Posted on 21 May 2002
By analyzing cells from a genetic syndrome called Fanconi's anemia, researchers at the Universitat Autonoma de Barcelona (Spain) found that breakages in the telomeric DNA sequence lead to accelerated telomere shortening. More...
Their findings were reported in the February 15, 2002, issue of Human Molecular Genetics.

Fanconi's anemia is a genetic syndrome characterized by a high genetic instability and chromosomal fragility. It causes a very high predisposition to cancer in those who harbor the syndrome, such as a risk of leukemia that is 15,000 times higher than that of a healthy person. The researchers found that the telomeres of patients with Fanconi's anemia showed an accelerated shortening, owing to breakages in their DNA sequence, which resulted in chromosomes being unprotected and joining together. This mechanism may explain the tendency of these patients to contract cancer.

The research provides the first experimental link between a predisposition to cancer and the mechanism of sudden shortening of telomeres. Telomeres are very important to the genetic integrity of cells. Ordinarily, they prevent the chromosomes from joining together, protect their ends from degradation, and are involved in segregating chromosomes properly during cell division. Telomeres gradually shorten, which then indicates the point at which the cell dies.




Related Links:
Univ. Autonoma of Barcelona
Human Molecular Genetics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Clinical Informatics Platform
CLARION™
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.